The UK has had real problems attracting firms to do clinical trials here in the last few years. The number of trial-starts dropped by almost half between 2015 and 2021 – from around 700 to 400. That was partly because a huge amount of capacity was diverted to Covid-related studies like the RECOVERY and […]
European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease Neuraxpharm Group announced that the European Commission (EC) has granted marketing authorisation under exceptional circumstances for NEZGLYAL® (leriglitazone), an orally bioavailable, brain penetrating, selective PPAR gamma agonist, as a treatment for male cALD patients, […]
Advanced Medical Solutions Group announced its unaudited interim results for the six months ended 30 June 2026 Advanced Medical Solutions Group plc (AIM: AMS), a world-leading specialist in tissue-healing technologies, announced its unaudited interim results for the six months ended 30 June 2026. Group revenue increased by 4% to £115.5 million and by 3% at […]
Optimum Strategic Communications and Catalyst Advisors LP will be hosting a 5K #LondonLandmarksRun during the #Jefferies Global Healthcare Conference and London Life Sciences Week! We are delighted to be partnering with Catalyst Advisors again to bring the life sciences community together for our London Landmarks Run Club on the morning of 17 November. It’s a […]
We need to talk about AI. Not its potential to revolutionise drug discovery, or the workplace, or even how it might threaten humanity. We need to talk about something more mundane – but still important. We need to talk about how to get AI to notice you. Because if AI is not noticing your firm, […]
